Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. - Wikidata - wikimedia - TriplyDB

Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes.

Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes.

http://www.wikidata.org/entity/Q43472325

about

Clinical significance of procoagulant microparticles Novel methodologies for biomarker discovery in atherosclerosis Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus.Microparticle Formation in Peritoneal Dialysis: A Proof of Concept Study.Parvovirus B19-induced vascular damage in the heart is associated with elevated circulating endothelial microparticles.Soluble platelet-endothelial cell adhesion molecule-1, a biomarker of ventilator-induced lung injury Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions.Endurance capacity is not correlated with endothelial function in male university students.Circulating CD62E+ microparticles and cardiovascular outcomes.Circulating microparticles: square the circle.Increased circulating endothelial apoptotic microparticle to endothelial progenitor cell ratio is associated with subsequent decline in glomerular filtration rate in hypertensive patients.Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease.Effects of high intensity training and high volume training on endothelial microparticles and angiogenic growth factors Claudin-5 levels are reduced from multiple cell types in human failing hearts and are associated with mislocalization of ephrin-B1.Circulating Microparticles and Coronary Plaque Components Assessed by Virtual Histology Intravascular Ultrasound of the Target Lesion in Patients with Stable Angina Microparticle Shedding from Neural Progenitor Cells and Vascular Compartment Cells Is Increased in Ischemic Stroke.Extracellular Vesicle Proteins Associated with Systemic Vascular Events Correlate with Heart Failure: An Observational Study in a Dyspnoea Cohort.Microparticle-Induced Coagulation Relates to Coronary Artery Atherosclerosis in Severe Aortic Valve Stenosis.Dexrazoxane Shows No Protective Effect in the Acute Phase of Reperfusion during Myocardial Infarction in Pigs Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity.Evaluation of Endothelial and Platelet Derived Microparticles in Patients with Acute Coronary Syndrome.Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction Effects of a nutraceutical combination on lipids, inflammation and endothelial integrity in patients with subclinical inflammation: a randomized clinical trial Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.Microparticles as novel biomarkers and therapeutic targets in coronary heart disease.Endothelial Microparticle-Derived Reactive Oxygen Species: Role in Endothelial Signaling and Vascular Function Plasma extracellular vesicle protein content for diagnosis and prognosis of global cardiovascular disease.Personalized cytomic assessment of vascular health: Evaluation of the vascular health profile in diabetes mellitus.Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases Extracellular vesicle protein levels are related to brain atrophy and cerebral white matter lesions in patients with manifest vascular disease: the SMART-MR study.Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro.Endothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors.Procoagulant activity of circulating microparticles is associated with the presence of moderate calcified plaque burden detected by multislice computed tomography.Physiologic and hematologic concerns of rotary blood pumps: what needs to be improved?Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis.Revisited role of microparticles in arterial and venous thrombosis.Microparticles in health and disease.Extracellular vesicle profiling and their use as potential disease specific biomarker.Central role of eNOS in the maintenance of endothelial homeostasis

P2860

Q26830846-0832D2B1-58B6-4A87-BD96-8F3318DF2D27 Q28088373-4283AF12-B44C-4147-8B34-99C96C7EBFC7 Q33659103-A43D9369-699F-4C11-8264-350381037F46 Q33693525-29E897CE-851F-466D-8E18-E1C5C3F281AE Q33712962-AA70937D-4D6B-4CAD-BA0F-72F1FB78D6D2 Q33754723-7E5851FE-E9E5-4253-8FE3-3A4C3090566E Q33968841-B044A8A8-1516-46FD-91CE-D9A71A7677C7 Q34015476-A7C89B29-BC5E-46BD-AFBE-C18AA091B72E Q34259709-9DC2DA0A-4554-468A-B6F5-8CC0FBFEA06A Q34680832-52EB4CAD-35FD-4167-A3B8-185231D3B155 Q34849981-A2372855-2F72-4668-8442-B6CCA217663D Q35067334-91E65148-3E3D-4436-8B79-A87A0C94FEE4 Q35114995-30E813D2-53F1-44AE-A64A-AD84D81C3D37 Q35158221-3CD96F57-59F3-4424-870C-55D68624F374 Q35582658-D1B1A801-E8B8-46B2-A5F0-D4DA2DB1BA00 Q35904860-D45CA4C4-ECC7-4C4D-AF38-11B0D12BD4EC Q35905659-B758CB10-FA3D-4B69-A929-549A1E4C3AAA Q35907034-828D5BED-E9FA-4249-9ADF-230393662C9C Q35968665-70A4BF79-9B7B-4624-BFDA-04B1CBF09AE9 Q36230443-10248DB3-A5EE-4DA2-8E78-6B1E2362134D Q36283002-0CA1D219-B2FB-4D50-9F62-787C8756C43E Q36476672-6D5C1CE4-3231-4AE1-95D4-6B13849D8C24 Q36645079-49D30F17-2D3C-47F2-A929-7FC6AD8DE2C3 Q36719448-A5BF1897-8437-422A-9A62-0D569AE91DB5 Q36745194-2CD436E2-7BEA-4C61-A7CC-57919F1E31D3 Q36816361-47B2277A-33B2-4D13-A2C8-169C14F76EA4 Q36970177-6BD7E937-E50A-45EC-8900-4C022A4B7A8A Q37179823-EC0D105F-2CDC-425D-847C-9543EBF96C05 Q37267758-27489AF4-AE46-4AFC-BE6B-E443A684B9EB Q37316399-856C3321-801A-462B-8B23-BD576E03A5C9 Q37517034-DE712356-D169-4935-8CFF-C9E46D7DA71D Q37535237-4AA9829A-6F6A-4A89-9F1F-8455DF7780AB Q37648544-3833BA7F-654C-4BAD-B27C-CB9194397236 Q37695163-7F1C529F-99CA-4202-9D05-6E5500AD361C Q38095401-A1BE5C71-B574-402C-B3B5-CCC98D0FF33F Q38106664-6ADC85C7-6844-4BDF-A8E4-2F2DFEE17354 Q38117725-DA1C36A4-490B-4C13-890F-DBADC9BD53CF Q38118341-ED035E7C-EB9C-40F0-B73D-EDED1A8A3BE5 Q38250056-11E4F49B-95BC-4113-B53A-D151F0D935CD Q38261420-B7A13495-925B-4A8C-8876-6F9B8BBD8977

P2860

Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes.

http://www.wikidata.org/entity/Q43472325

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes.

@en

Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes.

@nl

type

label

Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes.

@en

Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes.

@nl

prefLabel

Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes.

@en

Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes.

@nl

P1433

Q43472325-F0EDC24E-38A4-4BA5-AB5A-9D18C7C2A576

P1476

Q43472325-4D8C1C77-7BE2-4A65-AB49-DBFFB9BBE52B

P2093

Q43472325-31CF5C72-4DD5-4D85-A063-E26A2D395367

Q43472325-3E47D7E3-88BD-4083-8D89-924B8ED3CA7B

Q43472325-8E199866-9D22-480B-A3FF-EFEE75B08732

Q43472325-B6036B2D-2AAB-474E-9390-0C625850891F

Q43472325-B65325C9-B3F5-41A0-BC73-6E0D0E76142C

Q43472325-CFB1D7F6-19FB-4CDB-9D63-E91C7989594E

P2860

Q43472325-09F97972-E10D-40E8-B86B-3F78789D9528

Q43472325-11AF3261-FD79-4179-9EE0-33E899A7C1AB

Q43472325-14976D76-58FE-4591-8907-B226BF7EF10D

Q43472325-1AC3DBCE-B405-4641-AD04-16AF160D15D3

Q43472325-1B26A576-471F-470E-9217-8FA828BD04B9

Q43472325-22F8ECF0-12E0-4066-9F90-7A017CF02830

Q43472325-2886923B-01EE-4E1C-87DA-07AD4742ADDF

Q43472325-3BF58FA9-C7F0-42A5-9674-E970FB65A13F

Q43472325-453A93CC-80A1-47EC-A391-5D174DA3F619

Q43472325-4B37E720-1A78-48A9-9ED5-E3F285BCCDC1

P304

Q43472325-6AD79F7E-D29A-4CAF-AC5C-8E54DC340079

P31

Q43472325-48D634ED-2B32-4863-B4C0-19E205739A50

P356

Q43472325-B9E9F20E-9B41-42C2-A716-19180784981C

P433

Q43472325-ADF00927-A6BD-4E6A-8AD3-A02A92910AE1

P478

Q43472325-8A40E77F-C059-4EDE-ABB9-A1240F9654FA

P577

Q43472325-41CA2DD3-1B3D-4CD2-8285-9FEFBBAC47E7

P5875

Q43472325-729A421F-01AE-4474-B1B2-F125E2667FF5

P698

Q43472325-04E0633B-F6AF-4555-BB5E-90B9C0E58CCC

P921

Q43472325-45B2C928-5D00-42F9-9883-E4FDAB24A584

P356

P1433

European Heart Journal

P1476

Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes.

@en

P2093

Georg Nickenig

http://www.w3.org/2001/XMLSchema#string

Jan Losch

http://www.w3.org/2001/XMLSchema#string

Jan-Malte Sinning

http://www.w3.org/2001/XMLSchema#string

Katrin Walenta

http://www.w3.org/2001/XMLSchema#string

Michael Böhm

http://www.w3.org/2001/XMLSchema#string

Nikos Werner

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating endothelial progenitor cells and cardiovascular outcomes

Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection

Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro.

Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I.

Increased circulating endothelial microparticles and carotid atherosclerosis in obstructive sleep apnea.

Endothelial microparticles as markers of endothelial dysfunction.

New horizons in the analysis of circulating cell-derived microparticles.

Shed membrane microparticles from circulating and vascular cells in regulating vascular function.

Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?

Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease.

P304

2034-2041

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHQ478

http://www.w3.org/2001/XMLSchema#string

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49709809

http://www.w3.org/2001/XMLSchema#string

P698

21186238

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio